WPC
CVS icon

Waters Parkerson & Co’s CVS Health CVS Stock Holding History

Waters Parkerson & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
11,403
+3
+0% +$268 0.06% 101
2026
Q1 		$819K Buy
11,400
+100
+0.9% +$7.7K 0.04% 108
2025
Q4 		$897K Hold
11,300
– – 0.04% 105
2025
Q3 		$852K Sell
11,300
-85
-0.7% -$5.83K 0.04% 107
2025
Q2 		$785K Sell
11,385
-1,027
-8% -$67.3K 0.04% 111
2025
Q1 		$841K Sell
12,412
-329
-3% -$19.7K 0.04% 105
2024
Q4 		$572K Sell
12,741
-133,082
-91% -$7.47M 0.03% 127
2024
Q3 		$9.17M Sell
145,823
-258,803
-64% -$15.1M 0.47% 52
2024
Q2 		$23.9M Sell
404,626
-20,203
-5% -$1.26M 1.27% 30
2024
Q1 		$33.9M Sell
424,829
-2,078
-0.5% -$159K 1.74% 21
2023
Q4 		$33.7M Sell
426,907
-9,052
-2% -$644K 1.87% 18
2023
Q3 		$30.4M Buy
435,959
+11,516
+3% +$816K 1.82% 21
2023
Q2 		$29.3M Buy
424,443
+8,130
+2% +$578K 1.66% 23
2023
Q1 		$30.9M Buy
416,313
+6,708
+2% +$562K 1.83% 19
2022
Q4 		$38.2M Sell
409,605
-2,130
-0.5% -$206K 2.3% 13
2022
Q3 		$39.3M Sell
411,735
-720
-0.2% -$71.3K 2.63% 9
2022
Q2 		$38.2M Buy
412,455
+4,979
+1% +$486K 2.41% 9
2022
Q1 		$41.2M Buy
407,476
+6,448
+2% +$677K 2.3% 12
2021
Q4 		$41.4M Sell
401,028
-9,470
-2% -$875K 2.18% 14
2021
Q3 		$34.8M Sell
410,498
-512
-0.1% -$42.9K 2.01% 16
2021
Q2 		$34.3M Buy
411,010
+2,923
+0.7% +$239K 1.98% 16
2021
Q1 		$30.7M Buy
408,087
+11,661
+3% +$849K 1.89% 17
2020
Q4 		$27.1M Buy
396,426
+14,391
+4% +$936K 1.81% 17
2020
Q3 		$22.3M Buy
382,035
+1,776
+0.5% +$111K 1.68% 21
2020
Q2 		$24.7M Buy
380,259
+1,133
+0.3% +$71.3K 2% 15
2020
Q1 		$22.5M Buy
379,126
+19,122
+5% +$1.28M 2.18% 16
2019
Q4 		$26.7M Buy
360,004
+10,015
+3% +$703K 2% 19
2019
Q3 		$22.1M Buy
349,989
+20,235
+6% +$1.2M 1.78% 22
2019
Q2 		$18M Buy
329,754
+57,475
+21% +$3.1M 1.46% 27
2019
Q1 		$14.7M Buy
+272,279
New +$16.8M 1.23% 30

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Waters Parkerson & Co's CVS Position: Q2 2026 in Review

Waters Parkerson & Co increased its CVS Health (CVS) stake by 0.03% in Q2 2026, buying an estimated $268 and bringing the position to 11,403 shares worth $1.18M. The position accounts for 0.06% of the portfolio, ranked #101.

Waters Parkerson & Co first reported a position in CVS in Q1 2019 and has held it in 30 quarters since. The position peaked at $41.4M in Q4 2021. 1,276 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Waters Parkerson & Co held 11,403 shares of CVS Health worth $1.18M as of Q2 2026.
  • Waters Parkerson & Co bought 3 CVS Health shares in Q2 2026, an estimated $268.
  • CVS Health made up 0.06% of Waters Parkerson & Co's portfolio in Q2 2026, its #101 holding.
  • Waters Parkerson & Co first reported a position in CVS Health in Q1 2019 and has held it in 30 quarters since.
  • Waters Parkerson & Co's CVS Health position peaked at $41.4M in Q4 2021.
  • 1,276 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Waters Parkerson & Co's 13F filing for Q2 2026, filed 30 Jul 2026.